Camurus
Sweden - LundBiotechnology
Focus: Camurus is a Swedish specialty biotech company focused on developing innovative therapies in endocrinology, oncology, and gastroenterology, primarily leveraging its FluidCrystal® depot injection technology platform. With 201–500 employees, it operates as a publicly traded mid-cap biotech with a clinical-stage pipeline rather than significant marketed products.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
0
About Camurus
AI assessmentNot HiringNo open roles listed right now. Follow Camurus to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Camurus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
episil
Oral MucositisClinical Trials (1)
NCT01684566A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis
N/AHelp build intelligence for Camurus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.